Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bosentan in adults with Fontan circulation
2005-005898-29Phase 4Completed
- Sponsor
- University Hospitals Birmingham
- Start
- May 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of bosentan in Cardiovascular Malformation (CVM) and heart failure (HF), sponsored by University Hospitals Birmingham. Primary endpoints: Safety of oral bosentan therapy over 6 months, Hepatic dysfunction and 3 more. Started May 2008; status: completed.
02
Drugs
bosentan
03
Conditions
Cardiovascular Malformation (CVM)heart failure (HF)
Beyond the preview
Go deeper on 2005-005898-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005898-29.